Previous 10 | Next 10 |
Canadian Earnings Reports news releases related Canadian Earnings Reports news releases and Canadian Earnings Reports press releases from 04/03/24...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.95%Change Percent:
Olin Corporation Company Name:
OLN Stock Symbol:
NYSE Market:
olin.com Website: